Health Insurance Coverage for People with HIV Under the Affordable Care Act: Experiences in Five States

Executive Summary
  1. Myron S. Cohen, et al. “Prevention of HIV-1 Infection with Early Antiretroviral Therapy.” New England Journal of Medicine. 365(2011):493-505.

    ← Return to text

  2. Heather Bradley, et al. Centers for Disease Control and Prevention. “Vital Signs: HIV Diagnosis, Care, and Treatment Among Persons Living with HIV — United States, 2011.” Morbidity and Mortality Weekly Report. 63(47);1113-1117. November 28, 2014.

    ← Return to text

Issue Brief
  1. Myron S. Cohen, et al. “Prevention of HIV-1 Infection with Early Antiretroviral Therapy.” New England Journal of Medicine. 365(2011):493-505.

    ← Return to text

  2. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents. November 13, 2014. Accessed 12-15-14 at: http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0.

    ← Return to text

  3. Heather Bradley, et al. Centers for Disease Control and Prevention. “Vital Signs: HIV Diagnosis, Care, and Treatment Among Persons Living with HIV — United States, 2011.” Morbidity and Mortality Weekly Report. 63(47);1113-1117. November 28, 2014.

    ← Return to text

  4. Centers for Disease Control and Prevention. “Diagnoses of HIV Infection in the United States and Dependent Areas, 2012.” HIV Surveillance Report, 2012. vol. 24. November 2014. http://www.cdc.gov/hiv/library/reports/surveillance/.

    ← Return to text

  5. Heather Bradley, et al. Centers for Disease Control and Prevention. “Vital Signs: HIV Diagnosis, Care, and Treatment Among Persons Living with HIV — United States, 2011.” Morbidity and Mortality Weekly Report. 63(47);1113-1117. November 28, 2014.

    ← Return to text

  6. Myron S. Cohen, et al. “Prevention of HIV-1 Infection with Early Antiretroviral Therapy.” New England Journal of Medicine. 365(2011):493-505

    ← Return to text

  7. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents. November 13, 2014. Accessed 12-15-14 at: http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0

    ← Return to text

  8. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents. November 13, 2014. Accessed 12-15-14 at: http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0

    ← Return to text

  9. Heather Bradley, et al. Centers for Disease Control and Prevention. “Vital Signs: HIV Diagnosis, Care, and Treatment Among Persons Living with HIV — United States, 2011.” Morbidity and Mortality Weekly Report. 63(47);1113-1117. November 28, 2014.

    ← Return to text

  10. See for example: Jayanta Bhattacharya, Dana Goldman, and Neeraj Sood. “The Link Between Public and Private Insurance and HIV-related Mortality.” Journal of Health Economics, 22:6(2003):1105–22; Amy Finkelstein, et al. “The Oregon Health Insurance Experiment: Evidence from the First Year.” The Quarterly Journal of Economics, 127:3(2012): 1057-1106.; Melissa Majerol, Vann Newkirk, and Rachel Garfield. Kaiser Commission on Medicaid and the Uninsured. he Uninsured: A Primer - Key Facts About Health Insurance and the Uninsured in America. December 2014. Available at https://www.kff.org/uninsured/report/the-uninsured-a-primer/.; Patrick Sullivan, et al. “Time to First Annual HIV Care Visit and Associated Factors for Patients in Care for HIV Infection in 10 US Cities.” AIDS Care. Vol. 23 10(2011): 1314-1320; and Baligh R. Yehia, et al. “Sustained Viral Suppression in HIV-Infected Patients Receiving Antiretroviral Therapy.” JAMA, 308:4(2012): 339-42.

    ← Return to text

  11. Kaiser Family Foundation analysis of CDC surveillance data: Centers for Disease Control and Prevention. “Diagnoses of HIV Infection in the United States and Dependent Areas, 2012.” HIV Surveillance Report, 2012. vol. 24. Nov. 2014. http://www.cdc.gov/hiv/library/reports/surveillance/.

    ← Return to text

  12. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Ryan White HIV/AIDS Program 2012 State Profiles. Accessed 12-10-14: http://hab.hrsa.gov/stateprofiles/

    ← Return to text

  13. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Policy Clarification Notice 13-04: Clarifications Regarding Clients Eligible for Private Health Insurance and Coverage of Services by Ryan White HIV/AIDS Program. Revised September 2013. Available at: http://hab.hrsa.gov/manageyourgrant/pinspals/pcn1304privateinsurance.pdf

    ← Return to text

  14. E.G. Bing, et al. “Psychiatric Disorders and Drug Use Among Human Immunodeficiency Virus-Infected Adults in the United States.” Archives of General Psychiatry. 58:8(2001),721-8.

    ← Return to text

  15. Institute of Medicine. Public Financing and Delivery of HIV/AIDS Care: Securing the Legacy of Ryan White. (Washington DC: National Academies Press, 2005). (Accessed 12-15-14 at: http://iom.edu/Reports/2004/Public-Financing-and-Delivery-of-HIVAIDS-Care-Securing-the-Legacy-of-Ryan-White.aspx ).

    ← Return to text

  16. Jennifer Kates. Kaiser Family Foundation. Medicaid and HIV: A National Analysis. 2011. Available at: https://www.kff.org/wp-content/uploads/2013/01/8218.pdf

    ← Return to text

  17. Michael J. Mugavero, K. Rivet Amico, Tim Horn, and Melanie A. Thompson. “The State of Engagement in HIV Care in the United States: From Cascade to Continuum to Control.” Clinical Infectious Diseases.57:8(2013):1164–71.

    ← Return to text